Clinical trials sponsored by Hinova Pharmaceuticals Inc.

Phase breakdown

Conditions studied

Recruiting trials led by Hinova Pharmaceuticals Inc.

• A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients
  NCT06155084 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 27 locations
• A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
  NCT03851640 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )
  NCT07308548 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials is Hinova Pharmaceuticals Inc. recruiting for?

Hinova Pharmaceuticals Inc. is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.